Loading...
Bluejay Diagnostics, Inc.
BJDX•NASDAQ
HealthcareMedical - Devices
$2.25
$0.73(48.03%)
Bluejay Diagnostics, Inc. (BJDX) Financial Performance & Statements
Review Bluejay Diagnostics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
30.47%
↑ 30.47%
Net Income Growth
22.46%
↑ 22.46%
Operating Cash Flow Growth
5.94%
↑ 5.94%
Operating Margin
-3068.42%
↓ 3068.42%
Gross Margin
25.14%
↑ 25.14%
Net Profit Margin
-3356.89%
↓ 3356.89%
ROE
-114.23%
↓ 114.23%
ROIC
-167.38%
↓ 167.38%
Bluejay Diagnostics, Inc. (BJDX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Bluejay Diagnostics, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $216086.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $108043.00 | $0.00 | $53717.00 |
| Gross Profit | $0.00 | $108043.00 | $0.00 | -$53717.00 |
| Gross Profit Ratio | $0.00 | $0.50 | $0.00 | |
| R&D Expenses | $784800.00 | $553997.00 | $551655.00 | $1.03M |
| SG&A Expenses | $1.10M | $1.04M | $809952.00 | $809070.00 |
| Operating Expenses | $1.89M | $1.45M | $1.36M | $1.84M |
| Total Costs & Expenses | $0.00 | $1.70M | $1.36M | $1.90M |
| Interest Income | $17801.00 | $145823.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $729.00 | $190610.00 | $626471.00 |
| Depreciation & Amortization | $0.00 | $37482.00 | $53572.00 | $53717.00 |
| EBITDA | $0.00 | -$1.54M | -$1.24M | -$1.80M |
| EBITDA Ratio | $0.00 | -$7.12 | ||
| Operating Income | $0.00 | -$1.48M | -$1.36M | -$1.90M |
| Operating Income Ratio | $0.00 | -$6.87 | ||
| Other Income/Expenses (Net) | $0.00 | $52654.00 | -$120352.00 | -$580119.00 |
| Income Before Tax | -$1.86M | -$1.43M | -$1.48M | -$2.48M |
| Income Before Tax Ratio | -$6.63 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $3.00 |
| Net Income | -$1.86M | -$1.43M | -$1.48M | -$2.48M |
| Net Income Ratio | -$6.63 | |||
| EPS | -$3.37 | -$8.94 | -$9.25 | -$16.65 |
| Diluted EPS | -$3.37 | -$8.94 | -$9.25 | -$16.65 |
| Weighted Avg Shares Outstanding | $554012.00 | $160227.00 | $160227.00 | $148645.00 |
| Weighted Avg Shares Outstanding (Diluted) | $554012.00 | $160228.00 | $160228.00 | $148646.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan